Immunotherapy for advanced thyroid cancers — rationale, current advances and future strategies
Crossref DOI link: https://doi.org/10.1038/s41574-020-0398-9
Published Online: 2020-08-24
Published Print: 2020-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
French, Jena D. http://orcid.org/0000-0002-8881-6543
Text and Data Mining valid from 2020-08-24
Version of Record valid from 2020-08-24
Article History
Accepted: 15 July 2020
First Online: 24 August 2020
Competing interests
: J.D.F. is involved in a clinical trial funded by Merck and Eisai.